Suchergebnisse - "Dargan, Paul"

PubPharm (471)

1

Artificial intelligence in clinical pharmacology : A case study and scoping review of large language models and bioweapon potential

enthalten in: British journal of clinical pharmacology | 2024

von Rubinic, I. | Kurtov, M. | Rubinic, I. | +3

CommentIn: Br J Clin Pharmacol. 2023 Dec;89(12):3771-3772. - PMID 37828792

2

Comparison of recreational drug presentations to the emergency department in Europe, the Middle East and Northern Africa

enthalten in: European journal of emergency medicine : official journal of the European Society for Emergency Medicine | 2024

von De Baerdemaeker, K. | Dines, A. | Nefau, T. | +14

3

Correction : Neonatal blood lead concentration predicts medium term lead-related outcomes in children ≤5 years old with congenital lead poisoning: A retrospective cohort study in Northern Nigeria

enthalten in: PLOS global public health | 2024

von Thurtle, N. | Kirby, K. | Greig, J. | +4

ErratumFor: PLOS Glob Public Health. 2023 Mar 29;3(3):e0001644. - PMID 36989232

4

Artificial intelligence in clinical pharmacology : A case study and scoping review of large language models and bioweapon potential

enthalten in: British Journal of Clinical Pharmacology | 2024

von Rubinic, I. | Kurtov, M. | Rubinic, I. | +3

5

Self-discharge during treatment for acute recreational drug toxicity : an observational study from emergency departments in seven European countries

enthalten in: International journal of emergency medicine | 2023

von Vallersnes, O. | Dines, A. | Wood, D. | +17

6

Self-discharge during treatment for acute recreational drug toxicity: an observational study from emergency departments in seven European countries

enthalten in: International journal of emergency medicine | 2023

von Vallersnes, O. | Dines, A. | Wood, D. | +17

7

Immunogenicity and safety of AZD2816, a beta (B.1.351) variant COVID-19 vaccine, and AZD1222 (ChAdOx1 nCoV-19) as third-dose boosters for previously vaccinated adults : a multicentre, randomised, partly double-blinded, phase 2/3 non-inferiority immunobridging study in the UK and Poland

enthalten in: The Lancet. Microbe | 2023

von Ramasamy, M. | Kelly, E. | Seegobin, S. | +51

8

The Toxicology Investigators Consortium 2022 Annual Report

enthalten in: Journal of medical toxicology : official journal of the American College of Medical Toxicology | 2023

von Amaducci, A. | Campleman, S. | Li, S. | +109

9

Omicron BA.1-containing mRNA-1273 boosters compared with the original COVID-19 vaccine in the UK : a randomised, observer-blind, active-controlled trial

enthalten in: The Lancet. Infectious diseases | 2023

von Lee, I. | Cosgrove, C. | Moore, P. | +64

CommentIn: Lancet Infect Dis. 2023 Sep;23(9):984-985. - PMID 37348518

10

Determinants of Admission to Critical Care Following Acute Recreational Drug Toxicity : A Euro-DEN Plus Study

enthalten in: Journal of clinical medicine | 2023

von Noseda, R. | Franchi, M. | Pagnamenta, A. | +69

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[48]